Dr. Scott E. Eggener
Claim this profileUniversity of Chicago
Studies Prostate Cancer
Studies Stomach Cancer
10 reported clinical trials
16 drugs studied
Affiliated Hospitals
Clinical Trials Scott E. Eggener is currently running
Anti-inflammatory Drugs
for Elevated Prostate-Specific Antigen Levels
Prostate cancer is the most frequently diagnosed cancer in men in the Unites States. Nearly 1 million prostate biopsy procedures are performed in the United States annually and elevated prostate-specific antigen (PSA) level is the primary reason for prostate biopsy in \> 90% of cases. However, at the PSA levels which trigger prostate biopsy, often no cancer is found in prostate biopsy specimens. PSA test can be elevated due to reasons other than cancer such as inflammation or natural variation in the level. Investigators plan to treat men with elevated PSA level with over the counter anti-inflammatory medications (ibuprofen, naproxen) to see if the PSA level will decrease to an acceptable level.
Recruiting3 awards Phase 41 criteria
Prostatectomy
for Prostate Cancer
This randomized phase II trial studies how well surgical removal of the prostate and antiandrogen therapy with or without docetaxel work in treating men with newly diagnosed prostate cancer that has spread to other places in the body. Androgens can cause the growth of prostate cancer cells. Antiandrogen therapy may lessen the amount of androgens made by the body. Drugs used in chemotherapy, such as docetaxel work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Surgery, antiandrogen therapy and docetaxel may work better in treating participants with prostate cancer.
Recruiting1 award Phase 213 criteria
More about Scott E. Eggener
Clinical Trial Related4 years of experience running clinical trials · Led 10 trials as a Principal Investigator · 7 Active Clinical TrialsTreatments Scott E. Eggener has experience with
- Ibuprofen Or Naproxen
- MRI-guided Transurethral Ultrasound Ablation
- Ibuprofen
- Prostate MRI
- Biopsy
- Biospecimen Collection
Breakdown of trials Scott E. Eggener has run
Prostate Cancer
Chronic Bacterial Prostatitis
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Scott E. Eggener specialize in?
Scott E. Eggener focuses on Prostate Cancer and Stomach Cancer. In particular, much of their work with Prostate Cancer has involved Stage IV patients, or patients who are undergoing treatment.
Is Scott E. Eggener currently recruiting for clinical trials?
Yes, Scott E. Eggener is currently recruiting for 7 clinical trials in Chicago Illinois. If you're interested in participating, you should apply.
Are there any treatments that Scott E. Eggener has studied deeply?
Yes, Scott E. Eggener has studied treatments such as Ibuprofen or Naproxen, MRI-guided Transurethral Ultrasound Ablation, Ibuprofen.
What is the best way to schedule an appointment with Scott E. Eggener?
Apply for one of the trials that Scott E. Eggener is conducting.
What is the office address of Scott E. Eggener?
The office of Scott E. Eggener is located at: University of Chicago, Chicago, Illinois 60637 United States. This is the address for their practice at the University of Chicago.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.